Literature DB >> 14978025

Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells.

Sooryanarayana Varambally1, Yaron Bar-Dayan, Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Michael Horn, Marc Sorel, Yosefa Bar-Dayan, Giovina Ruberti, Michel D Kazatchkine, Srini V Kaveri.   

Abstract

Natural polyreactive IgM autoantibodies, encoded by unmutated germline Ig V genes, represent a major fraction of the normal circulating IgM repertoire. We have previously shown that therapeutic preparation of pooled IgM exerts immunomodulatory effects as assessed by in vitro and in vivo studies. Here, we show that the IgM preparation induces cell death in lymphoblastoid cell lines and in human peripheral blood mononuclear cells. The IgM-induced cell death involved classical features of apoptosis such as nuclear fragmentation and activation of caspases. Treatment of leukemic cells with IgM resulted in the cleavage of poly-(A)DP ribose polymerase, a substrate of caspase, and in a reduction in mitochondrial transmembrane potential during the early period of apoptosis induction. Natural IgM-induced apoptosis was inhibited by soluble Fas molecules and affinity-purified Fas antibodies from pooled IgM preparation induced apoptosis in lymphoblastoid cells, suggesting the involvement of the Fas receptor. Our results suggest a role for normal IgM in controlling cell death and proliferation, and imply a possible therapeutic role for IgM in autoimmune and lymphoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978025     DOI: 10.1093/intimm/dxh053

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.

Authors:  Jessica J Manson; Claudia Mauri; Michael R Ehrenstein
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

3.  IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.

Authors:  T Vassilev; N Mihaylova; E Voynova; M Nikolova; M Kazatchkine; S Kaveri
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 4.  Harnessing benefit from targeting tumor associated carbohydrate antigens.

Authors:  Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi; Laura F Hutchins; Angela Pennisi; Issam Makhoul
Journal:  Hum Vaccin Immunother       Date:  2017-02       Impact factor: 3.452

5.  Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.

Authors:  Marcela A Haro; Allison M Dyevoich; James P Phipps; Karen M Haas
Journal:  Cancer Res       Date:  2018-09-17       Impact factor: 12.701

6.  Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes.

Authors:  Sreenivasulu Gunti; Sarah E M Herman; Raju V S R K Gottumukkala; Ying Xiong; Clare Sun; Gilberto N Carmona; Adrian Wiestner; Abner L Notkins
Journal:  Leuk Lymphoma       Date:  2018-05-09

7.  Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis.

Authors:  Yulia A Savitskaya; Genaro Rico; Luis Linares; Roberto González; René Téllez; Eréndira Estrada; Norma Marín; Elisa Martínez; Alfonso Alfaro; Clemente Ibarra
Journal:  Biomark Cancer       Date:  2010-11-28

8.  Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation.

Authors:  Sreenivasulu Gunti; Ronald J Messer; Chengfu Xu; Ming Yan; William G Coleman; Karin E Peterson; Kim J Hasenkrug; Abner L Notkins
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

9.  Serum tumor markers in pediatric osteosarcoma: a summary review.

Authors:  Yulia A Savitskaya; Genaro Rico-Martínez; Luis Miguel Linares-González; Ernesto Andrés Delgado-Cedillo; René Téllez-Gastelum; Alfonso Benito Alfaro-Rodríguez; Antonio Redón-Tavera; José Clemente Ibarra-Ponce de León
Journal:  Clin Sarcoma Res       Date:  2012-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.